GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Qianjiang Yongan Pharmaceutical Co Ltd (SZSE:002365) » Definitions » 3-Year Revenue Growth Rate

Qianjiang Yongan Pharmaceutical Co (SZSE:002365) 3-Year Revenue Growth Rate : -6.70% (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Qianjiang Yongan Pharmaceutical Co 3-Year Revenue Growth Rate?

Qianjiang Yongan Pharmaceutical Co's Revenue per Share for the three months ended in Mar. 2024 was ¥0.67.

During the past 12 months, Qianjiang Yongan Pharmaceutical Co's average Revenue per Share Growth Rate was -36.80% per year. During the past 3 years, the average Revenue per Share Growth Rate was -6.70% per year. During the past 5 years, the average Revenue per Share Growth Rate was 0.50% per year. During the past 10 years, the average Revenue per Share Growth Rate was 10.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Qianjiang Yongan Pharmaceutical Co was 34.50% per year. The lowest was -11.60% per year. And the median was 8.10% per year.


Competitive Comparison of Qianjiang Yongan Pharmaceutical Co's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Qianjiang Yongan Pharmaceutical Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qianjiang Yongan Pharmaceutical Co's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Qianjiang Yongan Pharmaceutical Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Qianjiang Yongan Pharmaceutical Co's 3-Year Revenue Growth Rate falls into.



Qianjiang Yongan Pharmaceutical Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Qianjiang Yongan Pharmaceutical Co  (SZSE:002365) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Qianjiang Yongan Pharmaceutical Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Qianjiang Yongan Pharmaceutical Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Qianjiang Yongan Pharmaceutical Co (SZSE:002365) Business Description

Traded in Other Exchanges
N/A
Address
No. 2, Guangze Avenue, Qianjiang Economic Development Zone, Hubei Province, Wuhan, CHN, 433100
Qianjiang Yongan Pharmaceutical Co Ltd is a China-based company principally involved in the manufacturing of taurine products. The company sells its products in China and other international countries.
Executives
Mei Song Lin Executives
Wang Zhi Hua Executives
Hong Ren Gui Executives
Wu Yu Xi Directors, executives
Dai Xiang Zhen Executives
Wu Xiao Bo Directors, executives
Luo Bai Neng Executives
Ding Hong Li Directors, executives
Fang Xi Quan Executives
Li Shao Bo Executives
Deng Yong Hong Securities Affairs Representative
Dong Shi Hao Executives
Wu Guo Sen Supervisors
Lv Xin Wu Executives
Chen Yong Directors, executives

Qianjiang Yongan Pharmaceutical Co (SZSE:002365) Headlines

No Headlines